Medical Device News Magazine

C360 Spine Portfolio Unveiled – NuVasive Advises Launch Represents a Significant Opportunity for Growth As Cervical Spine Procedures Comprise An Approximately $2.6 Bil Segment of the Global Spine Market

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

November 30, 2020

NuVasive has expanded its product line with the introduction of a new C360 cervical spine portfolio. The company has also commercially launched its new anterior cervical plating (ACP) system, which is claimed to feature the thinnest plate on the market at 1.6mm.

NuVasive has designed a new ACP system to minimize common postoperative complications such as dysphagia, malalignment, and adjacent level ossification.

The system helps surgeons to customize treatment as per customer requirements compared to the traditional one-size-fits-all approach.

Features of new anterior cervical plating system

The new ACP system features three plate profiles, including a thin-plate for one and two levels, and offers optimized plate stiffness for each surgical level to support construct stability.

NuVasive’s system offers a range of implant length options to match different patient anatomies and maximize the distance from the adjacent levels.

In addition, the system consists of a range of advanced screw offerings with integrated locking covers to facilitate better screw placement and locking accuracy.

The C360 portfolio also includes the Reline Cervical posterior fixation system, which is expected to be commercialized in 2021.

NuVasive executive vice president Massimo Calafiore said: “As the leader in spine technology innovation, NuVasive saw an opportunity to procedurally integrate technology to support the cervical spine—as it did in the lateral market with X360—to optimize the surgeon experience and advance care in the operating room.

“The launch of C360 is key to our long-term strategy and represents a significant opportunity for growth, as cervical spine procedures comprise an approximately $2.6 billion segment of the global spine market.”

NuVasive offers procedural solutions, including access, implants and fixation systems, biologics, software for surgical planning, and navigation and imaging solutions.

In November, NuVasive expanded its Porous PEEK portfolio with the commercial introduction of a new Cohere extreme lateral interbody fusion (XLIF) system.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”